RENAU.UNSP.ARD 1/5 EO-20 - Asset Resilience Ratio
RENAU.UNSP.ARD 1/5 EO-20 (56S0) has an Asset Resilience Ratio of 0.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RENAU.UNSP.ARD 1/5 EO-20 (56S0) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how RENAU.UNSP.ARD 1/5 EO-20's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see RENAU.UNSP.ARD 1/5 EO-20 assets under control.
Liquid Assets Composition Over Time
This chart breaks down RENAU.UNSP.ARD 1/5 EO-20's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does RENAU.UNSP.ARD 1/5 EO-20 carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €28.90 Million | 0.37% |
| Total Liquid Assets | €28.90 Million | 0.37% |
Asset Resilience Insights
- Limited Liquidity: RENAU.UNSP.ARD 1/5 EO-20 maintains only 0.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
RENAU.UNSP.ARD 1/5 EO-20 Industry Peers by Asset Resilience Ratio
Compare RENAU.UNSP.ARD 1/5 EO-20's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SARTORIUS (UNSP.ADS)/1/5
F:SRT0 |
Medical Instruments & Supplies | 0.26% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987 |
Medical Instruments & Supplies | 0.01% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
AVE Science & Technology Co Ltd
SHG:688067 |
Medical Instruments & Supplies | 24.13% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 32.68% |
|
Nextgen
TA:NXGN |
Medical Instruments & Supplies | 3.13% |
Annual Asset Resilience Ratio for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for RENAU.UNSP.ARD 1/5 EO-20.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.10% | €8.10 Million ≈ $9.47 Million |
€7.98 Billion ≈ $9.33 Billion |
-0.02pp |
| 2024-12-31 | 0.12% | €9.90 Million ≈ $11.57 Million |
€8.26 Billion ≈ $9.65 Billion |
0.00pp |
| 2023-12-31 | 0.12% | €9.50 Million ≈ $11.11 Million |
€7.73 Billion ≈ $9.04 Billion |
-0.39pp |
| 2022-12-31 | 0.51% | €25.90 Million ≈ $30.28 Million |
€5.07 Billion ≈ $5.92 Billion |
-- |
About RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more